A detailed history of Autumn Glory Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Autumn Glory Partners, LLC holds 22,671 shares of NVO stock, worth $1.93 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
22,671
Previous 16,208 39.88%
Holding current value
$1.93 Million
Previous $2.31 Million 16.69%
% of portfolio
1.05%
Previous 1.18%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$119.07 - $145.42 $769,549 - $939,849
6,463 Added 39.88%
22,671 $2.7 Million
Q1 2024

Apr 30, 2024

SELL
$102.11 - $135.92 $306,330 - $407,759
-3,000 Reduced 15.62%
16,208 $2.08 Million
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $71,979 - $86,469
-820 Reduced 4.09%
19,208 $1.99 Million
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $1.09 Million - $2.4 Million
12,034 Added 150.54%
20,028 $1.82 Million
Q2 2023

Aug 02, 2023

BUY
$155.98 - $172.65 $1.25 Million - $1.38 Million
7,994 New
7,994 $1.29 Million
Q4 2022

Jan 31, 2023

SELL
$102.55 - $135.33 $22,253 - $29,366
-217 Reduced 1.95%
10,894 $1.47 Million
Q3 2022

Oct 26, 2022

BUY
$95.28 - $116.93 $827,792 - $1.02 Million
8,688 Added 358.56%
11,111 $1.11 Million
Q2 2022

Aug 08, 2022

SELL
$103.24 - $121.81 $1.21 Million - $1.43 Million
-11,732 Reduced 82.88%
2,423 $270,000
Q1 2022

May 04, 2022

SELL
$93.1 - $112.54 $1.03 Million - $1.25 Million
-11,095 Reduced 43.94%
14,155 $1.57 Million
Q4 2021

Feb 16, 2022

BUY
$95.88 - $117.08 $2.42 Million - $2.96 Million
25,250 New
25,250 $2.83 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Autumn Glory Partners, LLC Portfolio

Follow Autumn Glory Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Autumn Glory Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autumn Glory Partners, LLC with notifications on news.